A Naproxen (C14H14O3 M.W. =230) drug is a non-steroidal antiinflammatory agent. The drug was investigated by mass spectrometry (MS) at 70 and 12 eV of ionizing electron, and by thermal analysis (TA) measurements (TG/DTG and DTA). On the other hand, the calculations were performed on the neutral and charged species using semi-empirical molecular orbital (MO) calculation, PM3 procedure. These calculations included, bond length, bond order, bond strain, partial charge distribution, ionization energy and heats of formation (ΔHf). Mass spectral fragmentation (MS) and thermal analysis (TA) decomposition were proposed and compared to each other to select the most suitable scheme representing the correct fragmentation pathway of the drug in both techniques. MO calculations provide additional information about the first rupture and subsequent one as well as the stability of neutral and ionized species.
INTRODUCTION
Naproxen(NAP) has an IUPAC name, 2-Naphthaleneacetic acid, 6-methoxy-α-methyl-,(s)-(+)-(s)-6-Methoxy-α-methyl-2-naphthaleneacetic acid (1, 2) and general formula (C14H14O3). It belongs to a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by reducing hormones that cause inflammation and pain in the body. NAP is used to treat pain or inflammation caused by conditions such as arthritis, ankylosing spondylitis, tendinitis, bursitis, or menstrual cramps (3) (4) (5) .
Mass spectrometry (MS) is one of the most powerful analytical techniques, particularly for pharmaceutical analysis, where good selectivity and high sensitivity are often needed. In the pharmaceutical industry measurements of drugs and their metabolites in plasma are essential for drug discovery and development. The more accurate and rapid measurements, is the more quickly a drug can progress towards regulatory approval. Time-of-flight mass spectrometer (TOF-MS) delivers high sensitivity, resolution, and exact mass measurements. A variety of ion source and software options makes MS a versatile choice for a range of analytical challenges (6) (7) (8) (9) (10) Thermal analytical techniques can provide important information regarding storage and stability of pharmaceuticals. Thermal analytical methods have thus become important tools for the development of modern medicines (11) (12) (13) (14) (15) . These are precise and accurate techniques with low sample requirements, and can provide detailed information about new chemical entities even at the very earliest stages of discovery and development of the new compositions and drugs (16) (17) (18) (19) . Thermo gravimetric TG/DTG analysis used to provide quantitative information on weight losses due to decomposition and /or evaporation of low molecular materials as a function of time and temperature. In conjunction with mass spectrometric analysis (20) (21) (22) (23) , the nature of the released volatilize may be deduced, thus great facilitating the interpretation of thermal degradation processes. On the other hand, computational quantum chemistry can provide additional information about the atoms and bonds, which can be used successfully in an interpretation of experimental results (24) . Application of computational quantum chemistry in addition to experimental results (MS and TA) gives valuable information about the atoms and bonds which helps in the description and prediction of primary fragmentation site of cleavage and subsequent one (25) (26) (27) (28) .
The aim of the present work is focusing on further application of our previous work (25) (26) (27) (28) to the case of NAP drug. This work includes a correlation between, mass spectral fragmentation and thermal analysis degradation of the drug and comparing these experimental data with the theoretical Molecular Orbital (MO) calculation to identify the weakest bonds ruptured during both mass and thermal studies. Consequently the choice of the correct pathway of such fragmentation knowing this structural session of bonds can be used to decide the active sites of this drug responsible for its chemical, biological and medical reactivity.
EXPERIMENTAL

Materials:
All chemicals used were of the analytical reagent grade (AR), and of highest purity available. They included NAP (M.wt = 230.26 g mole), as an authentic sample which was kindly supplied by Egyptian Drug Control Authority (EDCA), Cairo (Egypt).
Mass spectrometry (MS):
Electron ionization (EI) mass spectrum of NAP is obtained using Thermo Finnegan TRACE DSQ quadruple mass spectrometer with electron multiplier detector equipped with GC-MS data system at Experimental Nuclear Physics -Nuclear Research Center. The direct probe (DIP) for solid material was used in this study. The sample was put into a glass sample micro vial, by a needle (≈ 1 μg max), the vial installed on the tip of the DP containing heating cable and inserted into the evacuated ion source. The sample was ionized by electron beam emitted from the filament, the generated ions being effectively introduced into the analyzer by the focusing and extractor lenses system. The MS was continuously scanned and the obtained spectra were stored. Electron ionization mass spectra were obtained at ionizing energy value of 70 and 12 eV, ionization current of 60 μA and vacuum is better than 10 -6 torr.
Thermal analyses (TA):
The thermal analyses of NAP drug were made using conventional thermal analyzer (Shimadzu system of DTA-50 and 30 series TG-50) at Cairo University micro-analytical center. The mass losses of 5 mg sample and heat reopens of the change of the sample were measured from room temperature up to 600 ºC. The heating rate, in an inert argon atmosphere, was selected as 10 ºC min-1. These instruments were calibrated using indium metal as a thermal stable material. The reproducibility of the instrument reading was determined by repeating each experiment more than twice.
Computational method:
The MO calculations were performed using semi-empirical molecular orbital calculation. The method used in these computations is the parametric method (PM-3) described by Stewart (29) . The default criteria for terminating all optimizations were increased by a factor of 100 (keyword PRECISE). All the molecular orbital calculations were carried out at the restricted Hartree-Fock level (RHF) for the neutral molecule of NAP while the unrestricted Hartree-Fock level (UHF) were carried out for its cation by using PM-3 method followed by full optimization of all geometrical variables (bond lengths, bond angles, and dihedral angles), without any symmetry constraint. All structures were optimized to a gradient norm 0.01-0.05, using the eigenvector following (EF) routine (30) . All the semi empirical MO calculations were performed with the MOPAC2000 software package (31) implemented on an Intel Pentium IV 3.0 G Hz computer.
RESULTS AND DISCUSSION
It is of great interest to study the chemistry and reactivity of NAP drug because of its importance in medicine. The geometrical structure of NAP is shown in Fig. 1 . Knowledge obtained from thermal decomposition mechanisms of the neutral drug is very important to understand the chemical process that shared in biological systems. It is difficult to establish the exact major fragmentation pathway in EI using conventional MS. With combining the above two techniques and the data obtained from the MO calculation, it is possible to understand the following topics:
1. Stability of the drug under thermal degradation in solid state and mass spectral fragmentation in gas phase. 2. Prediction of the primary site of bond rupture and subsequent one. 3. The correct pathways under TA and MS techniques. 4 . Understanding what actually happened in biodegradation of the drug or its derivatives in vivo system and metabolites.
Thermal analysis:
The TA data of NAP are illustrated in Figs.2a and 2b. It is clear from TG/DTG curves ( 
Mass spectral (MS) fragmentation of NAP drug:
The electron ionization (EI) mass spectrum for NAP drug measured at 70 and 12 eV was Recorded (Figs. 3a, b) and investigated. The proposed fragmentation pathway is shown in scheme 2. The spectrum of NAP drug at 70 eV (Fig. 3a) is characterized by many competitive and consecutive pathways, thus forming many intense fragment ions (scheme 2). The main fragmentation pathways for NAP after ionization of neutral molecule at 8.764 eV consists of three principal pathways (path1-3) as rationalized in scheme 2. The signal that appears at m/z = 230 (RI = 100%) refers to the appearance of the main molecular ion At the low energy value of 12 eV (Fig.3b) , the base peak observed at molecular ion m/z = 230, R.I.= 100%) and it is noted that the peaks corresponding secondary process (m/z = 185) observed at RI < 10%. Comparing the data in Fig. 3a to that in Fig. 3b , refers to the fact that at 70 eV it is sufficient energy for fragmentation of NAP (mole mass 230) to give its daughter fragment ion [C13H13O] + (m/z = 185, R.I. = 90.42%), but at 12 eV the lower energy is insufficient to give this fragment from its parent drug molecule. This also confirms the proposed mass scheme 2, which indicates that the path 2 is the only possible way to form [C13H13O] + at 70 eV. This is also confirmed by the full scan MS/MS spectrum (32) ( Fig.4) 
Computational Molecular Orbital (MO) calculation:
Molecular orbital (MO) calculation gives valuable information about the structure and reactivity of the molecules, which actually be used to support the experimental evidence (21) (22) (23) (25) (26) (27) (28) . The much important parameters calculated using MO calculation which includes bond orders, bond length, charge distribution, bond strain, heat of formation and ionization energy. In the present work, the calculations have been carried out on NAP neutral molecule (related to TA decomposition) and charged molecular ion (related to MS fragmentation) which is used for prediction of weakest bond rupture to follow the fragmentation pathways in both techniques. The order of the bond strength: C21-O22>C1-C2>C9-C10>C7-C8>C3-C4>C5-C6>C8-C9>C6-C7>C10-C5>C4-C4>C6-C1>C2-C3>C15-O16>C3-O11>O11-C12>C13-C14>C8-C13>C13-C15. 1. Small differences in bond length in NAP system upon ionization, indicating that no appreciable change in the geometries upon ionization. 
Correlation between thermal analysis (TA) decomposition and MO-calculation:
As indicated, the determination of initial bond rupture would be an important first step in using this calculation in predicative manner. MO calculation, PM3 procedure reveal that the C13-C15 bond has the lowest bond order at 0.919 and large bond length= 1.521 Å and bond strain= 0.032 kcal mol -1 . Experimental TA curves (Fig. 2) of NAP reveal that the first weight loss equal to 19.13%. This weight loss corresponding to the rupture of COOH (lowest bond order) at temperature 157 o C of range 150-170 o C, followed by rupture of C3-O11 bond (bond order= 1.037, bond length=1.364 Å, bond strain= 0.032 kcal mol -1 ). This second weight loss of a value 13.65% at temperature and range 180-280 o C. This weight loss is mainly due to rupture of OCH3 (O+CH3). This wide range of temperature may due to slow fragmentation with small half life time, since in TA decomposition the molecule are continuously energized and determined by a gas evolution and the distribution of energy can be described by energy (34) .
On the other hand, the electrostatic repulsion between C13 (-0.012) and C15(-0.386) for neutral, facility the rupture of this bond (C13-C15), than the second rupture C3 (-0.100) and O11 (-0.187) atoms, indicating that the COOH loss is more easy than O-CH3 loss.
Correlation between mass spectral (MS) fragmentation and MO calculations of charged molecule:
The scope of this investigation is restricted to a search for prediction of the first and subsequent bond ruptures during the course of fragmentation of NAP drug in MS technique. The subsequent fragmentation in MS is determined to large extent by the initial bond rupture of molecular ion (28) (29) (30) (31) . A number of mass spectrometric techniques have utilized helping in rationalized the correct pathways of the molecules, among which are: threshold measurement and metastable abundance ratios (17) . On the other hand, computational can provide important information which can be used successfully in description of primary site of cleavage. These theoretical data can particularly, valuable for MS because they study in gas phase species, which can be handled much more easily by quantum chemistry (29) (30) (31) . Mass spectrum of NAP reveals (scheme2) three competitive and consecutive fragmentation pathways.
PM3 procedure reveals that the C13-C15 (Table 1) Table 3 . These data refer to ordering of its bond strength is given by C9-C10>C1-C2>C3-C4>C8-C13>C7-C8>C6-C7>C4-C5>C2-C3>C5-C6>C6-C1>C10-C5>C8-C9>C3-O11>C13-C14> O11-C12. This means that, the first ruptured bond is O11-C12 leading to formation of fragment ion m/z= 170 [C12H10O] + via loss of CH3 group , followed by the rupture of the bond C13-C14 leading to the formation of m/z = 154 (RI = 12.85%) via the loss of CH3O and finally to the rupture of the bond C3-O11 leading to the formation of fragment ion [C11H7] + that observed at m/z = 139. This means that all fragment ions are coming from the daughter m/z = 185 not from the parent ion m/z =230. This is also is in good agreement with the proposed thermal and mass schemes (1 and 2) and MS/MS data (32) . The order of the bond strength: C9-C10>C1-C2>C3-C4>C8-C17>C7-C8>C6-C7>C4-C5>C2-C3>C5-C6>C6-C1>C10-C5>C8-C9>C3-O11>C13-C14>O11-C12
Correlation between TA and MS:
It is important to make a discussion between results of TA and MS of NAP, to see the behavior of the drug in both techniques. This comparison shows the agreement between mass path-1 and TA. In both TA and MS techniques, it is proved that the C13-C15 bond is the first site of rupture. In TA, COOH rupture is followed by OCH3 (O+CH3) (scheme1). In MS fragmentation it is initiated by COOH rupture and followed by CH3 group rupture in path-1 (scheme 2). The obtained fragment ions in MS are m/z = 230, 185, 170, 154 and 139, that confirmed by TA can be considered as a vitro metabolites of NAP drug; which are very similar to vivo urinary metabolites of NAP obtained by liquid chromatography-electro-spray mass spectrometry (35) .
CONCLUSION
The aim of this study is concerning with applicability of experimental TA and MS techniques and theoretical investigation MO calculations, using PM3 procedure on NAP drug. From correlation between MS and MO calculations, it is clear that the C13-C15 bond is the first site of bond cleavage. This refers to lowest bond order, large bond length and less bond strain. On the other hand, the electrostatic repulsion between the charges localized on C13 and C15 atoms facility the COOH molecule. Therefore, this investigation concluded that the correlation between both practical and theoretical techniques helps in the selection of the proper pathway representing the decomposition of this drug to give its vitro metabolites. From the obtained data of both practical (TA, MS) and theoretical (MO) techniques in this investigation, it is proved that, the C13-C15 bond is the first site of rupture in TA, COOH followed by OCH3 (O+CH3), while in MS the rupture initiated by COOH rupture followed by CH3 group. MO calculations reveal that the C13-C15 bond has the lowest bond order, large bond length and bond strain. Also, the electrostatic repulsion between C17 and C21 for neutral and cationic NAP forms facilitates the rupture of the bond (C13-C15). The charges on atoms C3 and O11make the second bond C3-O11 rupture is less possible. This indicates that the COOH loss is easier than O-CH3 loss. NAP can be complete thermally dissociated in the temperature range of 80-480 oC (mass loss = 99.0%).
The obtained fragment ions in MS are m/z = 230, 185, 170, 154 and 139, that confirmed by TA can be considered as a vitro metabolites of NAP drug. These vitro metabolites are suggested and confirmed by MO calculation and are very similar to vivo urinary metabolites of NAP obtained by liquid chromatography-electro-spray mass spectrometry (35) .
